Commerce Bank’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$890K Sell
18,568
-2,933
-14% -$126K ﹤0.01% 782
2026
Q1
$790K Buy
21,501
+1,971
+10% +$93.4K ﹤0.01% 793
2025
Q4
$994K Sell
19,530
-1,399
-7% -$71.5K 0.01% 674
2025
Q3
$1.16M Sell
20,929
-1,853
-8% -$108K 0.01% 634
2025
Q2
$1.57M Sell
22,782
-274
-1% -$18.6K 0.01% 530
2025
Q1
$1.6M Sell
23,056
-8,603
-27% -$711K 0.01% 510
2024
Q4
$2.72M Sell
31,659
-875
-3% -$94.6K 0.02% 435
2024
Q3
$3.87M Buy
32,534
+4,489
+16% +$599K 0.02% 372
2024
Q2
$4M Buy
28,045
+2,501
+10% +$331K 0.03% 345
2024
Q1
$3.28M Sell
25,544
-1,035
-4% -$123K 0.02% 406
2023
Q4
$2.75M Buy
26,579
+3,703
+16% +$366K 0.02% 425
2023
Q3
$2.08M Sell
22,876
-678
-3% -$59.7K 0.02% 442
2023
Q2
$1.91M Sell
23,554
-158
-0.7% -$12.9K 0.01% 461
2023
Q1
$1.89M Sell
23,712
-238
-1% -$16.9K 0.01% 439
2022
Q4
$1.62M Sell
23,950
-670
-3% -$39.3K 0.01% 469
2022
Q3
$1.23M Buy
24,620
+744
+3% +$39.9K 0.01% 510
2022
Q2
$1.33M Buy
23,876
+820
+4% +$45.5K 0.01% 513
2022
Q1
$1.28M Sell
23,056
-52
-0.2% -$2.67K 0.01% 545
2021
Q4
$1.29M Sell
23,108
-398
-2% -$21.6K 0.01% 564
2021
Q3
$1.13M Buy
23,506
+518
+2% +$25K 0.01% 579
2021
Q2
$963K Sell
22,988
-478
-2% -$18.5K 0.01% 620
2021
Q1
$791K Buy
23,466
+5,384
+30% +$192K 0.01% 664
2020
Q4
$632K Buy
18,082
+570
+3% +$19.7K 0.01% 696
2020
Q3
$608K Sell
17,512
-15,960
-48% -$532K 0.01% 637
2020
Q2
$1.1M Buy
33,472
+15,344
+85% +$490K 0.01% 486
2020
Q1
$546K Buy
18,128
+3,086
+21% +$91.9K 0.01% 557
2019
Q4
$435K Buy
15,042
+1,904
+14% +$52.7K ﹤0.01% 690
2019
Q3
$340K Sell
13,138
-2,720
-17% -$68.8K ﹤0.01% 738
2019
Q2
$404K Sell
15,858
-1,454
-8% -$35.9K ﹤0.01% 674
2019
Q1
$453K Buy
17,312
+924
+6% +$22.7K 0.01% 594
2018
Q4
$378K Buy
16,388
+504
+3% +$11.2K ﹤0.01% 619
2018
Q3
$374K Sell
15,884
-114
-0.7% -$2.78K ﹤0.01% 671
2018
Q2
$369K Buy
15,998
+322
+2% +$7.65K ﹤0.01% 663
2018
Q1
$386K Sell
15,676
-58
-0.4% -$1.52K 0.01% 645
2017
Q4
$422K Buy
15,734
+1,306
+9% +$33.2K 0.01% 621
2017
Q3
$348K Buy
14,428
+3,916
+37% +$88.5K ﹤0.01% 660
2017
Q2
$226K Buy
+10,512
New +$212K ﹤0.01% 766
2016
Q4
Sell
-11,252
Closed -$234K 829
2016
Q3
$234K Sell
11,252
-4,324
-28% -$107K ﹤0.01% 726
2016
Q2
$418K Sell
15,576
-1,438
-8% -$39.4K 0.01% 548
2016
Q1
$461K Buy
17,014
+1,592
+10% +$42.7K 0.01% 516
2015
Q4
$448K Sell
15,422
-422
-3% -$11.7K 0.01% 517
2015
Q3
$430K Sell
15,844
-520
-3% -$14.7K 0.01% 533
2015
Q2
$448K Sell
16,364
-252
-2% -$7.08K 0.01% 553
2015
Q1
$444K Buy
16,616
+50
+0.3% +$1.15K 0.01% 563
2014
Q4
$351K Hold
16,566
0.01% 629
2014
Q3
$394K Sell
16,566
-1,294
-7% -$29.8K 0.01% 569
2014
Q2
$413K Buy
17,860
+1,760
+11% +$38.9K 0.01% 569
2014
Q1
$367K Sell
16,100
-3,340
-17% -$71.2K 0.01% 586
2013
Q4
$359K Sell
19,440
-180
-0.9% -$3.14K 0.01% 571
2013
Q3
$332K Sell
19,620
-5,570
-22% -$93.7K 0.01% 578
2013
Q2
$390K Buy
+25,190
New +$419K 0.01% 532

Other funds holding NVO

Commerce Bank's NVO Position: Q2 2026 in Review

Commerce Bank reduced its Novo Nordisk (NVO) stake by 14% in Q2 2026, selling an estimated $126K and leaving 18,568 shares worth $890K. The position accounts for ﹤0.01% of the portfolio, ranked #782.

Commerce Bank first reported a position in NVO in Q2 2013 and has held it in 51 quarters since. The position peaked at $4M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Commerce Bank held 18,568 shares of Novo Nordisk worth $890K as of Q2 2026.
  • Commerce Bank sold 2,933 Novo Nordisk shares in Q2 2026, an estimated $126K.
  • Novo Nordisk made up ﹤0.01% of Commerce Bank's portfolio in Q2 2026, its #782 holding.
  • Commerce Bank first reported a position in Novo Nordisk in Q2 2013 and has held it in 51 quarters since.
  • Commerce Bank's Novo Nordisk position peaked at $4M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.